Emergent BioSolutions | 市值



金融业
股票价格
USD
资产
USD 1.82B
现金及等价物
USD 111.7M
销售成本
USD 381.2M
流动资产
USD 679.5M
流动负债
USD 651.3M
债务
USD 903.2M
股息收益率
0
EBIT
USD -148.1M
EBITDA
USD -113.5M
员工
1.6K
EPS每股收益
USD -0.77
股本和储备
USD 649.3M
销售毛利
USD 10M
债务利息支出
USD 17.9M
贷款资金
USD 446.5M
市值
USD 120.6M
净收入
USD -261.3M
营业费用
USD 555.9M
营业利润
USD -218M
普通股股本
USD 100K
PE价格收益
14.4
税前利润
USD -130.8M
销售收入
USD 276.6M
销售和管理费用
USD 182.8M
股票
USD 328.9M
贸易债权人
USD 112.2M
应收帐款人
USD 290.1M


市值 更改 日
Acadia Pharmaceuticals USD 3.6B 10M 2025-09
Akebia Therapeutics USD 322M 180M 2025-06
ALKERMES USD 5.65B 696M 2026-02
Alnylam Pharmaceuticals USD 39.74B 12.8B 2026-02
Amarin USD 341M 4M 2025-09
ANI Pharmaceuticals USD 2.04B 630M 2025-09
BioMarin Pharmaceutical USD 10.4B 142M 2025-09
Coherus Biosciences USD 278M 184M 2025-06
Emergent BioSolutions USD 125M 51M 2023-12
Exact Sciences USD 10.36B 334M 2025-09
Exelixis USD 12.27B 523M 2026-02
Glaxosmithkline GBP 106.96B 20.08B 2026-02
Heron Therapeutics USD 145M 6M 2023-09
Ionis Pharmaceuticals USD 10.43B 4.14B 2025-09
Ironwood Pharmaceuticals USD 213M 97M 2025-09
Lexicon Pharmaceuticals USD 267M 294M 2023-09
Lonza CHF 39.68B 980.61M 2025-06
Merck USD 300.37B 39.11B 2026-02
Moderna USD 16.5B 6.41B 2026-02
Myriad Genetics USD 494M 316M 2025-06
Nektar Therapeutics USD 113M 4M 2023-09
Neurocrine Biosciences USD 13.68B 465M 2026-02
Pacira USD 1.16B 51M 2025-09
Pfizer USD 152.89B 11.32B 2026-02
PTC Therapeutics USD 4.88B 1B 2025-09
Sanofi EUR 100.88B 4.46B 2025-12
Sarepta Therapeutics USD 2.02B 336M 2025-09
United Therapeutics USD 18.96B 6B 2025-09
Vanda Pharmaceuticals USD 243M 136M 2023-12
Xoma USD 162M 55M 2023-09


Emergent BioSolutions 市值 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.